SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity

BACKGROUND: The SARS-CoV-2 pandemic currently prevails worldwide. To understand the immunological signature of SARS-CoV-2 infections and aid the search and evaluation of new treatment modalities and vaccines, comprehensive characterization of adaptive immune responses towards SARS-CoV-2 is needed. M...

Descripción completa

Detalles Bibliográficos
Autores principales: Nielsen, Stine SF, Vibholm, Line K, Monrad, Ida, Olesen, Rikke, Frattari, Giacomo S, Pahus, Marie H, Højen, Jesper F, Gunst, Jesper D, Erikstrup, Christian, Holleufer, Andreas, Hartmann, Rune, Østergaard, Lars, Søgaard, Ole S, Schleimann, Mariane H, Tolstrup, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176920/
https://www.ncbi.nlm.nih.gov/pubmed/34098342
http://dx.doi.org/10.1016/j.ebiom.2021.103410

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8176920/
https://www.ncbi.nlm.nih.gov/pubmed/34098342
http://dx.doi.org/10.1016/j.ebiom.2021.103410

Ejemplares similares